中国药业2025，Vol.34Issue(4)：36-40,5.DOI:10.3969/j.issn.1006-4931.2025.04.010
2020-2022年某三级甲等综合医院国家谈判药品落地实践研究
Practical Research on the Use of National Negotiated Drugs in a Grade-A Tertiary General Hospital from 2020 to 2022
摘要
Abstract
Objective To analyze the allocation and use of national negotiated drugs in grade-A tertiary general hospitals.Methods The information related to national negotiated drugs,″dual-channel″ drugs and special drugs released by the National Healthcare Security Administration,Jiangsu Healthcare Security Administration and Yangzhou Healthcare Security Administration from 2019 to 2021 was collected,the data of drug use in the hospital from 2020 to 2022 were analyzed based on the hospital information system.Results The overall variety allocation ratios of national negotiated drugs from 2020 to 2022 were 33.90%,33.94%,40.00%respectively,the proportions of consumption sum were 4.72%,7.00%,9.43%respectively;among them,the Chinese patent medicines were mainly transferred to the national negotiated drug catalogue,with small consumption sum.Under the″dual-channel″ policy,the consumption sum and proportion of outpatient negotiated drugs significantly increased(from CNY 1.283 1 million to CNY 31.115 9 million,from 3.91%increased to 49.39%).Transfer-in/transfer-out of the national negotiated drug catalogue had a certain effect on the drug consumption sum.Conclusion The accessibility of national negotiated drugs is constantly improving,and the main responsibility of designated medical institutions for separate payment drugs still needs to be further strengthened.Clinical needs shoud be considered simultaneously during the selection of new drugs to negotiate to avoid there is no market demand after negotiated drugs entering the medical insurance catalogue.Multi-party collaboration is needed for the connection management mode of transfer-out drugs to improve the motivation of medical institutions.关键词
国家谈判药品/三级甲等综合医院/"双通道"管理/药品可及性Key words
national negotiated drug/grade-A tertiary general hospital/″dual-channel″ management/drug accessibility分类
医药卫生引用本文复制引用
孙家艳,顾云霞,陈春玲,徐文俊,朱华,谈定玉..2020-2022年某三级甲等综合医院国家谈判药品落地实践研究[J].中国药业,2025,34(4):36-40,5.基金项目
江苏省药学会-正大天晴医院药学科研基金[Q202238] （）
江苏省中药骨干人才高级研修项目[苏中医科教[2022]17号]. （）
